Double-blind, placebo-controlled study of ketanserin versus propranolol on platelet function in hypertensive patients
Davì, G.; Francavilla, G.; Catalano, I.; Mogavero, A.; Mattina, A.; Strano, A.
Annali Italiani di Medicina Interna Organo Ufficiale Della Societa Italiana di Medicina Interna 3(1): 43-47
1988
ISSN/ISBN: 0393-9340 PMID: 3152837 Document Number: 323445
Document emailed within 1 workday
Related Documents
Rao, A.K.; Ghosh, S.; Sun, L.; Yang, X.; Disa, J.; Pickens, P.; Polansky, M. 1995: Mechanisms of platelet dysfunction and response to DDAVP in patients with congenital platelet function defects. a double-blind placebo-controlled trial Thrombosis and Haemostasis 74(4): 1071-1078Gerber, W.D.; Schellenberg, R.; Thom, M.; Haufe, C.; Bölsche, F.; Wedekind, W.; Niederberger, U.; Soyka, D. 1995: Cyclandelate versus propranolol in the prophylaxis of migraine--a double-blind placebo-controlled study Functional Neurology 10(1): 27-35
Appelberg, B.G.; Syvälahti, E.K.; Koskinen, T.E.; Mehtonen, O.P.; Muhonen, T.T.; Naukkarinen, H.H. 2001: Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study Journal of Clinical Psychiatry 62(6): 448-452
Bretlau, P.; Thomsen, J.; Tos, M.; Johnsen, N.J. 1984: Placebo effect in surgery for Meniere's disease: a three-year follow-up study of patients in a double blind placebo controlled study on endolymphatic sac shunt surgery American Journal of Otology 5(6): 558-561
Romero-Vecchione, E.; Vásquez, J.; Velasco, M.; Morales, E.; Davoli, M.A.; Arocha, I. 1995: Increase of renal dopamine production induced by nifedipine in hypertensive patients. Double blind vs placebo study Archivos del Instituto de Cardiologia de Mexico 65(6): 535-540
van Riemsdijk, I.C.; Mulder, P.G.; de Fijter, J.W.; Bruijn, J.A.; van Hooff, J.P.; Hoitsma, A.J.; Tegzess, A.M.; Weimar, W. 2000: Addition of isradipine (Lomir) results in a better renal function after kidney transplantation: a double-blind, randomized, placebo-controlled, multi-center study Transplantation 70(1): 122-126
Fauvel, J.P.; Najem, R.; Maakel, N.; Pozet, N.; Laville, M. 1998: Effects of moxonidine on stress-induced peak blood pressure and renal function: a randomized, double-blind, placebo-controlled crossover study Journal of Cardiovascular Pharmacology 32(3): 495-499
Santamaria, F.; Sestito, M.; Lirato, C.; Di Palma, A.; De Rosa, M.L.; Iannuzzi, L.; Pandolfi, E.; Cicatiello, A.M.; Parlati, S. 1993: Acute effects of propranolol and its association with nifedipine in aged patients with effort stable angina. Randomized double-blind crossover study, under placebo control Minerva Cardioangiologica 41(4): 139-145
Karniol, I.G.; Portela, W. 1982: Oxprenolol in schizophrenic patients with tardive dyskinesia: a double-blind placebo-controlled, crossover study Brazilian Journal of Medical and Biological Research 15(6): 389-394
Rogers, S.L.; Doody, R.S.; Mohs, R.C.; Friedhoff, L.T. 1998: Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group Archives of Internal Medicine 158(9): 1021-1031
Tielemans, C.; Gastaldello, K.; Husson, C.; Marchant, A.; Delville, J.P.; Vanherweghem, J.L.; Goldman, M. 1999: Efficacy of oral immunotherapy on respiratory infections in hemodialysis patients: a double-blind, placebo-controlled study Clinical Nephrology 51(3): 153-160
Silny, W.; Czarnecka-Operacz, M. 2006: Specific immunotherapy in the treatment of patients with atopic dermatitis--results of double blind placebo controlled study Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 21(126): 558-565
Kirmaz, C.; Bayrak, P.; Yilmaz, O.; Yuksel, H. 2005: Effects of glucan treatment on the Th1/Th2 balance in patients with allergic rhinitis: a double-blind placebo-controlled study European Cytokine Network 16(2): 128-134
Sobaniec, W.; Kułak, W.; Smigielska-Kuzia, J.; Boćkowski, L.; Majkowski, J.; Jedrzejczak, J. 2004: A multicenter, placebo-controlled, double-blind study of efficacy of a new form of carbamazepine (Carbatrol) in refractory epileptic patients Polish Journal of Pharmacology 56(2): 195-201
Moldofsky, H.; Lue, F.A.; Mously, C.; Roth-Schechter, B.; Reynolds, W.J. 1996: The effect of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo controlled, modified crossover study Journal of Rheumatology 23(3): 529-533
Marriott, D.J.; Jones, P.D.; Hoy, J.F.; Speed, B.R.; Harkness, J.L. 1993: Fluconazole once a week as secondary prophylaxis against oropharyngeal candidiasis in HIV-infected patients. A double-blind placebo-controlled study Medical Journal of Australia 158(5): 312-316
Sadoul, P. 1983: Vectarion International Multicentre Study (VIMS): a long term double blind placebo controlled trial in COLD patients European Journal of Respiratory Diseases. Supplement 126: 357-361
Sinha, P.K.; Ambesh, S.P. 2004: Ondansetron in prophylaxis of postoperative nausea and vomiting in patients undergoing breast surgery: a placebo-controlled double blind study Journal of the Indian Medical Association 102(2): 73
Dive, A.; Miesse, C.; Galanti, L.; Jamart, J.; Evrard, P.; Gonzalez, M.; Installé, E. 1995: Effect of erythromycin on gastric motility in mechanically ventilated critically ill patients: a double-blind, randomized, placebo-controlled study Critical Care Medicine 23(8): 1356-1362
Littman, B.H.; Bjarnason, D.; Bryant, G.; Engelbrecht, J.; Cohen, M.; Mertz, L.; Weaver, A.; Hunder, G.G. 1995: Steroid sparing activity of tenidap in patients with polymyalgia rheumatica: a multicenter double blind randomized placebo controlled study Journal of Rheumatology 22(6): 1097-1103